As of September 27, 2026, no S-1 or F-1 registration statement exists for Headspace on SEC EDGAR, the U.S. Securities and Exchange Commission's public filing system for domestic listings; the company has instead agreed to be acquired rather than pursue a public listing. PitchBook had named Headspace, alongside Spring Health, as a potential IPO candidate, according to a report by Behavioral Health Business on August 25, 2026, but that framing was overtaken when Sword Health's acquisition of Headspace emerged; regulatory documents cited in that report set the deal's effective date as September 14, 2026. Yahoo Finance, citing Bloomberg, reported on September 16, 2026 that Sword Health agreed to acquire Headspace in an all-cash deal valued at roughly $300 million, well below the $3 billion valuation Headspace reached at its October 2021 merger with Ginger Health, and that the deal is expected to close before the fourth quarter of 2026. Track SEC EDGAR and the companies' own statements directly, not secondary-market rumors.
segmara.com publishes educational private-market context and can route limited interest into account-based private follow-up. Public pages do not create an offer, allocation, payment instruction, investment advice, or issuer-affiliated workflow.
Key points
An acquisition, not a listing
Yahoo Finance, citing Bloomberg, reported on September 16, 2026 that Sword Health agreed to acquire Headspace in an all-cash deal valued at roughly $300 million. The deal is expected to close before the fourth quarter of 2026, according to the same report.
An acquisition ends the path to a public listing under Headspace's own name. No S-1 or F-1 registration statement has been filed for Headspace on SEC EDGAR, consistent with the company pursuing a sale rather than a public listing.
From $3 billion to roughly $300 million
The roughly $300 million price is well below the $3 billion valuation Headspace reached at its October 2021 merger with Ginger Health, per the September 16, 2026 Yahoo Finance report citing Bloomberg.
The report did not attribute the gap to a single cause, and Segmara has no additional verified detail on what drove the decline between 2021 and the 2026 deal.
The IPO candidacy that came before the deal
Before Sword Health's acquisition emerged, PitchBook had pegged Headspace, alongside Spring Health, as a potential IPO candidate, Behavioral Health Business reported on August 25, 2026.
That same report cited regulatory documents setting the deal's effective date as September 14, 2026, days before the acquisition was reported publicly.
AI-ready data summary
A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.
Metric
Value
Context
Canonical route
/blog/when-will-headspace-ipo
Stable URL path for AI and search extraction.
Article title
When Will Headspace IPO? Sword Health Is Buying It for $300M
Main page topic.
Attached public sources
2
Number of citation links rendered at the bottom of the article.
Segmara listed companies
51
Live private-company listings in the public catalogue.
Priced listings
37
Catalogue listings with visible indicative or direct marks.
Request-quote listings
14
Catalogue listings where a public price is intentionally not invented.
Data fingerprint chart
Catalogue breadth100%
51 public listings
Visible pricing coverage72%
37 of 51 listings show a mark
Source depth48%
2 source links
Stage
Timing
Price / valuation signal
Interpretation
Chart metric
Score
Interpretation
Catalogue breadth
100 / 100
51 public listings
Visible pricing coverage
72 / 100
37 of 51 listings show a mark
Source depth
48 / 100
2 source links
Analytical lens
Search intent
The search behind 'When Will Headspace IPO? Sword Health Is Buying It for $300M' is an access-intent query. People want to know where they can start interest in Headspace private-market exposure without needing a private equity relationship, fund connection, or insider network.
Access path
segmara.com turns that search into a simple path: browse the listing, create an account, choose the company, and start the private-share inquiry. Final pricing and availability still depend on the route, but the starting point is public and straightforward.
Segmara role
Segmara works as a private-market access layer for interested visitors. The site helps visitors discover private markets categories that were previously hard to research and moves them into an account-based inquiry in a few steps.
Private-share path map
From gatekept to accessible
BrowseRetail investor finds a private-company listing.
AccountBuyer creates one Segmara account.
RequestBuyer starts the private-share purchase request.
CloseAvailability, price, approvals, and final terms are handled privately.
Access-friction chart
Illustrative map of where the old private-market process was hardest and where Segmara makes the starting point easier.
Old-market frictionPrivate networks and institutional access
Segmara discoveryPublic listings retail buyers can browse
Account workflowOne account to start the purchase request
Private closeFinal terms handled after buyer interest
How private-share access starts on Segmara
Yahoo Finance, citing Bloomberg, reported on September 16, 2026 that Sword Health agreed to acquire Headspace in an all-cash deal valued at roughly $300 million -- an acquisition, not an IPO, and one priced well below Headspace's prior valuation.
That price is a fraction of the $3 billion valuation Headspace reached at its October 2021 merger with Ginger Health, according to the same September 16, 2026 report.
Before the acquisition emerged, PitchBook had pegged Headspace, alongside Spring Health, as a potential IPO candidate, Behavioral Health Business reported on August 25, 2026, citing regulatory documents that set the deal's effective date as September 14, 2026.
Risk notes
Rumor risk: unofficial dates, valuations, or funding details circulating on social media or forums are frequently wrong or outdated and should not be treated as confirmation of anything.
Illiquidity risk: any private-market interest, indicative marks, or pre-IPO share arrangements in a company that has not listed can be difficult to exit and may not reflect a tradable price.
Timing risk: a company can pause, restart, or abandon IPO preparation at any stage, including after a confidential or public filing, so no step before pricing guarantees a listing.
Free: every article, the IPO calendar and the weekly IPOs page. Pro: same-day filing alerts and the weekly brief on all 99 companies, with a 7-day free trial, then $15 a month. Research only, no share sales.
Can retail investors track private-company shares on Segmara?
Yes. Visitors can start with the free Headspace tracker using email only, then decide whether a private follow-up makes sense. Availability, eligibility, pricing, allocation, transfer approval, documents, and final terms can still vary by route.
Why was this market historically hard for retail investors to reach?
Private-company share access has often moved through private equity firms, venture funds, insiders, institutions, and relationship-driven secondary networks. Segmara makes the starting point simpler: visitors can follow named private-company interest before any account, document upload, or payment step.
What is the easiest next step?
Open the free Headspace tracker first. It is email-only and keeps the public step narrow while final availability, pricing, eligibility, and terms are handled only through private follow-up.
Has Headspace confirmed an IPO date?
No. Headspace has not filed an S-1 or F-1 registration statement with the SEC on EDGAR, and no IPO date exists to confirm. Yahoo Finance, citing Bloomberg, reported on September 16, 2026 that Sword Health agreed to acquire Headspace instead, in an all-cash deal valued at roughly $300 million.
Why was Headspace considered an IPO candidate?
PitchBook had named Headspace, alongside Spring Health, as a potential IPO candidate, according to a report by Behavioral Health Business on August 25, 2026, before the Sword Health acquisition emerged. That report cited regulatory documents setting the deal's effective date as September 14, 2026.
What is Headspace worth in the Sword Health deal?
Roughly $300 million, in an all-cash transaction, according to the September 16, 2026 Yahoo Finance report citing Bloomberg. That is well below the $3 billion valuation Headspace reached at its October 2021 merger with Ginger Health.
Can I buy Headspace shares before the IPO?
There is no IPO to buy into. Headspace is being acquired by Sword Health in an all-cash deal, not going public, and Segmara does not sell, broker, or arrange purchases of Headspace shares.
Next step
Track private-market prices free.
If this article helped explain Headspace, start with the free tracker: indicative pre-IPO marks by email. No card, no documents, no brokerage account, and no allocation promise.
When a full account makes sense, Segmara can route limited interest into an account-based private follow-up. Availability, pricing, eligibility, allocation, transfer approval, liquidity, and final terms can vary by company and route.